end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccountsReceivableNetCurrent,AccruedIncomeTaxesCurrent,AccruedLiabilitiesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation,AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet,AdvertisingExpense,AllocatedShareBasedCompensationExpense,AllowanceForDoubtfulAccountsReceivable,AllowanceForDoubtfulAccountsReceivableCurrent,AmortizationOfFinancingCosts,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,AreaOfRealEstateProperty,Assets,AssetsCurrent,AssetsNet,AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax,AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax,AvailableForSaleDebtSecuritiesAmortizedCostBasis,AvailableForSaleSecurities,AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax,AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax,AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax,AvailableForSaleSecuritiesAmortizedCost,AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue,AvailableForSaleSecuritiesDebtSecurities,AvailableForSaleSecuritiesDebtSecuritiesCurrent,AvailableForSaleSecuritiesDebtSecuritiesNoncurrent,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsPeriodIncreaseDecrease,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockDividendsShares,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ContractWithCustomerLiabilityCurrent,ContractWithCustomerLiabilityNoncurrent,ContractWithCustomerLiabilityRevenueRecognized,ConvertibleLongTermNotesPayable,CostMethodInvestments,CostOfGoodsSold,CumulativeEffectOnRetainedEarningsNetOfTax1,CurrentIncomeTaxExpenseBenefit,DebtInstrumentInterestRateStatedPercentage,DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months,DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss,DebtSecuritiesAvailableForSaleUnrealizedLossPosition,DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss,DeferredIncomeTaxExpenseBenefit,DeferredIncomeTaxLiabilities,DeferredRentCreditNoncurrent,DeferredRevenueCurrent,DeferredRevenueNoncurrent,DeferredTaxAssetsCapitalLossCarryforwards,DeferredTaxAssetsDeferredIncome,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsGross,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilities,DeferredTaxLiabilitiesPrepaidExpenses,DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries,Depreciation,DepreciationDepletionAndAmortization,DueFromRelatedPartiesCurrent,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxContingencies,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,EquityMethodInvestmentOwnershipPercentage,EquityMethodInvestments,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,ExcessTaxBenefitFromShareBasedCompensationOperatingActivities,FairValueAssetsLevel1ToLevel2TransfersAmount,FairValueAssetsLevel2ToLevel1TransfersAmount,FairValueLiabilitiesLevel1ToLevel2TransfersAmount,FairValueLiabilitiesLevel2ToLevel1TransfersAmount,FinanceLeaseRightOfUseAssetAmortization,GainLossOnSaleOfBusiness,GainsLossesOnExtinguishmentOfDebt,ImpairmentOfInvestments,ImpairmentOfLongLivedAssetsToBeDisposedOf,IncentiveToLessee,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,IncomeLossFromEquityMethodInvestments,IncomeTaxExpenseBenefit,IncomeTaxesPaid,IncomeTaxesPaidNet,IncomeTaxesReceivableNoncurrent,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInAccruedIncomeTaxesPayable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInContractWithCustomerLiability,IncreaseDecreaseInDeferredCharges,IncreaseDecreaseInDeferredRevenue,IncreaseDecreaseInDueFromRelatedPartiesCurrent,IncreaseDecreaseInIncomeTaxesReceivable,IncreaseDecreaseInInterestPayableNet,IncreaseDecreaseInInventories,IncreaseDecreaseInOperatingLeaseLiability,IncreaseDecreaseInOtherNoncurrentLiabilities,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInOtherReceivables,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,IncreaseDecreaseInPrepaidExpensesOther,IncreaseDecreaseInPrepaidTaxes,IncreaseDecreaseInRestrictedCash,InterestExpense,InterestExpenseDebt,InterestPaid,InterestPaidNet,InterestPayableCurrent,InventoryAdjustments,InventoryFinishedGoodsNetOfReserves,InventoryNet,InventoryRawMaterialsNetOfReserves,InventoryWorkInProcessNetOfReserves,InventoryWriteDown,InvestmentIncomeAmortizationOfPremium,InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermDebt,MarketableSecuritiesUnrealizedGainLoss,NetCashProvidedByUsedInContinuingOperations,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetIncomeLoss,NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1,NumberOfOperatingSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsDueThereafter,OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAccruedLiabilitiesCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,OtherDepreciationAndAmortization,OtherIncome,OtherLiabilitiesCurrent,OtherLiabilitiesNoncurrent,OtherLongTermInvestments,OtherNoncashIncomeExpense,OtherNonoperatingIncomeExpense,OtherPrepaidExpenseCurrent,OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings,OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet,PaymentsForPostemploymentBenefits,PaymentsForProceedsFromShortTermInvestments,PaymentsOfDebtIssuanceCosts,PaymentsOfLoanCosts,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,PaymentsToAcquireAvailableForSaleSecurities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,PaymentsToAcquireProductiveAssets,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PreferredStockValue,PrepaidExpenseAndOtherAssetsCurrent,PrepaidTaxes,ProceedsFromContributionsFromAffiliates,ProceedsFromContributionsFromParent,ProceedsFromDivestitureOfBusinessesNetOfCashDivested,ProceedsFromIncomeTaxRefunds,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromIssuanceOfPrivatePlacement,ProceedsFromIssuanceOfSeniorLongTermDebt,ProceedsFromSaleAndCollectionOfNotesReceivable,ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities,ProceedsFromSaleAndMaturityOfMarketableSecurities,ProceedsFromSaleOfAvailableForSaleSecurities,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,ProceedsFromSaleOfProductiveAssets,ProceedsFromSaleOfPropertyPlantAndEquipment,ProceedsFromStockOptionsExercised,ProceedsFromStockPlans,ProductLiabilityContingencyAccrualPresentValue,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,RepaymentsOfLongTermDebtAndCapitalSecurities,RepaymentsOfNotesPayable,ResearchAndDevelopmentExpense,RestrictedCash,RestrictedCashAndCashEquivalents,RestrictedCashAndCashEquivalentsNoncurrent,RestrictedCashCurrent,RestrictedCashNoncurrent,RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated,RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated,RestructuringCharges,RestructuringReserve,RestructuringReserveAccrualAdjustment1,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,Revenues,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,SalesRevenueGoodsNet,SellingGeneralAndAdministrativeExpense,SeveranceCosts1,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost,SharePrice,StockGrantedDuringPeriodValueSharebasedCompensation,StockholdersEquity,StockholdersEquityNoteSpinoffTransaction,StockIssuedDuringPeriodSharesNewIssues,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueRestrictedStockAwardGross,StockIssuedDuringPeriodValueStockOptionsExercised,TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit,TenantImprovements,UndistributedEarningsOfForeignSubsidiaries,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions,UnrecognizedTaxBenefitsPeriodIncreaseDecrease,ValuationAllowanceDeferredTaxAssetChangeInAmount,ValuationAllowancesAndReservesAdjustments,ValuationAllowancesAndReservesBalance,ValuationAllowancesAndReservesChargedToCostAndExpense,ValuationAllowancesAndReservesDeductions,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesIssuedBasic,WeightedAverageNumberOfSharesOutstandingBasic,WeightedAverageNumberOfSharesRestrictedStock,ForeignCurrencyTransactionGainLossBeforeTax,GainLossOnSaleOfPropertyPlantEquipment,PaymentsForRestructuring,RestructuringAndRelatedCostExpectedCost1,SubleaseIncome
2014-03-31,2014-06-24,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,4984000.0,3000.0,,,,,,,,,,,12701000.0,0.0,209000.0,,519000.0,,26167000.0,15600000.0,,,,,,,,,,,,,,0.0,,,,,,,,,,-60018000.0,,,,,,188000.0,,,,,,,,,,,4891000.0,7732000.0,648000.0,,,,,,,,,,,,,,,,,,732000.0,,,-1.89,,,,,,,,,,,,,13417000.0,,,,,0.0,0.0,,,,,,,,,,,-60018000.0,,,0.0,,,,-1094000.0,-196000.0,,4563000.0,,-117000.0,-412000.0,,,,617000.0,,0.0,0.0,-844000.0,1811000.0,,,,,,,,,,4792000.0,11014000.0,3997000.0,2225000.0,0.0,0.0,,,,,,,,,,,26167000.0,38544000.0,,,0.0,,46419000.0,,-1620000.0,,-44799000.0,-60018000.0,,,60963000.0,-60018000.0,,,,,,,,,,,,,,,9890000.0,,0.0,,,,2521000.0,,,,0.0,,,,,,,,0.0,0.0,,,1620000.0,,,,,,4493000.0,,,46419000.0,,,,,,,0.0,0.0,,,,,,,,,,9734000.0,,,41723000.0,,,833000.0,,,,,,,,,,945000.0,,945000.0,19052000.0,,12701000.0,,,,,,-17916000.0,,,,,,,,,,,,,,,,,,,,,,31741000.0,,,,,,,,
2014-06-30,2014-08-14,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,9499000.0,90000.0,,,,70000.0,405221000.0,,,,,,6764000.0,,306000.0,,1972000.0,,430588000.0,382733000.0,,,,,374975000.0,,,,374905000.0,,,80997000.0,38231000.0,268199000.0,,,,,0.0,200000000.0,32260000.0,32260000.0,,-58195000.0,,,,,,279000.0,,,,,,,,,,,4989000.0,5723000.0,729000.0,,,,14100000.0,,,,,,,,,,,,,,,15243000.0,,-1.83,,,,,,,,,,,,,6482000.0,92000.0,,,,,,0.0,0.0,0.0,0.0,,,,,,,-56492000.0,,,1723000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5614000.0,14756000.0,6864000.0,2278000.0,,,,,,,,,,,,,430588000.0,40111000.0,,,,,,,,,,-58215000.0,,,59680000.0,-56706000.0,,,,,,,,,,,,,,,13869000.0,,20000.0,,,,4538000.0,,,,214000.0,,,,,,,,,,,,,0.0,230000.0,0.0,0.0,,3446000.0,,,,,,,,,,,,,,,,,,,,,9624000.0,,,46283000.0,,,0.0,,,,,,,,-20532000.0,,2974000.0,,861000.0,13118000.0,,,,,,,,384759000.0,,,,,,,,,,0.0,,0.0,,,,,,,,,,31768000.0,32260000.0,,492000.0,,,,,
2014-09-30,2014-11-12,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,5284000.0,230000.0,5216000.0,,,-27000.0,414875000.0,,,,,,9350000.0,,47000.0,,4039000.0,,381705000.0,306711000.0,,,,,337537000.0,70000.0,,97000.0,337564000.0,,,162489000.0,65638000.0,122228000.0,,,,,0.0,200000000.0,32228000.0,32228000.0,,-54592000.0,,,,,,369000.0,,,,,,,,,,,5070000.0,667000.0,,,,,17100000.0,,,,,,,,,,,,,,,,,-1.72,,,,,,,,,,,,,10886000.0,,,,,,,0.0,0.0,0.0,0.0,,,,,,,-49394000.0,,,5101000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7490000.0,15129000.0,6827000.0,812000.0,,,,,,,,,,,,,381705000.0,35828000.0,,,,,,,,,,-54495000.0,,,56398000.0,-50062000.0,,,,,,,,,,,,,,,9435000.0,,-97000.0,-97000.0,,,4340000.0,986000.0,,,668000.0,,,,,,,,,,,,,0.0,230000.0,0.0,0.0,,6454000.0,,,,,,,,,,,,,,,,,,,,,9356000.0,,,38324000.0,,,0.0,,,,,,,,-75027000.0,,6336000.0,,1303000.0,17705000.0,,,,,,,,339821000.0,,,,,,,,,,400000.0,,,,,,,,,,,,31754000.0,,,,,,,,
2014-12-31,2015-03-13,10-K,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,9921000.0,289000.0,,,54468000.0,-82000.0,429206000.0,178000.0,43454000.0,282000.0,282000.0,1100000.0,43234000.0,0.0,87000.0,,3899000.0,,337771000.0,275370000.0,,,,,287494000.0,42000.0,,124000.0,287576000.0,,,165396000.0,51399000.0,89215000.0,,,,32260105.0,0.0,200000000.0,32221000.0,32221000.0,,-237211000.0,,,,,,4058000.0,,6364000.0,,,,,,,0.0,384000.0,5150000.0,89000.0,,,0.0,,19171000.0,0.0,384000.0,181000.0,29000.0,821000.0,7489000.0,7489000.0,2563000.0,18787000.0,-384000.0,384000.0,,2700000.0,3274000.0,,,-9.48,,-0.0276,0.0,-0.0242,,-0.0099,0.0,0.0,-0.001,0.0,-0.0025,-0.01,18156000.0,,96904000.0,,,282000.0,282000.0,0.0,0.0,0.0,0.0,,,,,,1400000.0,-230674000.0,-230674000.0,,6364000.0,4550000.0,4550000.0,,3917000.0,90000.0,0.0,11680000.0,,-376000.0,-7991000.0,-14635000.0,,,6628000.0,,866000.0,211000.0,906000.0,2878000.0,2878000.0,0.0,833000.0,0.0,,0.0,,,,5571000.0,12546000.0,6830000.0,145000.0,2887000.0,612000.0,,,,,,,,,,,337771000.0,41256000.0,,-173000.0,89215000.0,,370621000.0,,-106251000.0,,-175155000.0,-301348000.0,,1.0,311413000.0,-298292000.0,,,,,,,,,,,,,,,5219000.0,506000.0,-173000.0,-173000.0,,1600000.0,5219000.0,1578000.0,0.0,0.0,1865000.0,6084000.0,,,,-878000.0,,,178000.0,168893000.0,,,3107000.0,0.0,230000.0,0.0,0.0,,6084000.0,0.0,277541000.0,92976000.0,,,0.0,,0.0,0.0,140000.0,65564000.0,,900000.0,,,,0.0,0.0,,64131000.0,9663000.0,,,168522000.0,,800000.0,833000.0,,,,,,,,-139337000.0,,13121000.0,,4418000.0,71647000.0,,43234000.0,,,,,43454000.0,289787000.0,0.0,,,,,,,,0.0,1059000.0,0.0,,1018000.0,0.0,,5800000.0,,,,,,31755000.0,,,,,,,,
2015-03-31,2015-05-13,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,4021000.0,565000.0,,,,31000.0,470895000.0,,,,,,15626000.0,,433000.0,,4748000.0,,324901000.0,275556000.0,,,,,252142000.0,,,,,,,135337000.0,38521000.0,100899000.0,,,,32260105.0,0.0,200000000.0,33802000.0,33802000.0,,-42361000.0,,,,,,371000.0,,,,,,,,,,,5044000.0,310000.0,,,,,22200000.0,,,,,,,,,,,,,,825000.0,,,-1.29,,,,,,,,,,,,,10433000.0,,,,,391000.0,391000.0,0.0,0.0,0.0,0.0,,,,,,,-37526000.0,,,4948000.0,765000.0,,,-5431000.0,276000.0,,-6184000.0,,106000.0,212000.0,,,,41000.0,,321000.0,180000.0,,674000.0,664000.0,10000.0,,,,,,,,5586000.0,12337000.0,6751000.0,0.0,79000.0,239000.0,,,,,,,,,,,324901000.0,28852000.0,,,11684000.0,,26044000.0,,42154000.0,,-56514000.0,-42474000.0,,,58138000.0,-37737000.0,,,,,,,,,,,,,,,,686000.0,113000.0,113000.0,,,7460000.0,1890000.0,,,211000.0,,,,,,,,100000.0,10659000.0,,,657000.0,0.0,230000.0,0.0,0.0,,6758000.0,,,0.0,,,25753000.0,,,,,53470000.0,,,,,,,,,,9305000.0,,,36019000.0,,,833000.0,,,,,,,,-181811000.0,,20401000.0,,1280000.0,21748000.0,,15626000.0,,,,,,289115000.0,,,,,,,,,,1400000.0,,,,,,,,,,,,32830000.0,,,,,,,,
2015-06-30,2015-08-13,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,6335000.0,805000.0,,,,25000.0,487064000.0,,,,,,14662000.0,,482000.0,,6944000.0,,289479000.0,260226000.0,,,,,207680000.0,,,,,,,113896000.0,17794000.0,97090000.0,,,,,0.0,200000000.0,33939000.0,33939000.0,,-47610000.0,,,,,,505000.0,,,,,,,,,,,4895000.0,342000.0,,,,,24300000.0,,,,,,,,,,,,,,,,,-1.42,,,,,,,,,,,,,7793000.0,,,,,,,0.0,0.0,0.0,0.0,,,,,,,-45089000.0,,,2514000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5239000.0,12553000.0,7314000.0,0.0,,,,,,,,,,,,,289479000.0,24477000.0,,,,,,,,,,-47603000.0,,,52427000.0,-45293000.0,,,,,,,,,,,,,,,,1017000.0,-7000.0,-7000.0,,,3333000.0,2433000.0,,,204000.0,,,,,,,,,,,,,0.0,230000.0,0.0,0.0,,10394000.0,,,,,,,,,,,,,,,,,,,,,9609000.0,,,30377000.0,,,833000.0,,,,,,,,-229415000.0,,7134000.0,,2124000.0,21545000.0,,,,,,,,257674000.0,,,,,,,,,,1900000.0,,,,,,,,,,,,33532000.0,,,,,,,,
2015-09-30,2015-11-12,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,5963000.0,783000.0,,,,43000.0,499232000.0,,,,,,12251000.0,,579000.0,,6887000.0,,257506000.0,238239000.0,,,,,68856000.0,,,,,0.0,,68856000.0,0.0,127114000.0,,,,,0.0,200000000.0,33935000.0,33935000.0,,-47295000.0,,,,,8000000.0,581000.0,,,,,,,,,,,4746000.0,271000.0,,,,,28000000.0,,,,,,,,,,,,,,,,,-1.4,,,,,,,,,,,,,10222000.0,,,,,,,0.0,0.0,0.0,0.0,,,,,,,-42991000.0,,,4323000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4827000.0,12141000.0,7314000.0,0.0,,,8000000.0,,,,,,,,,,257506000.0,27430000.0,,,,,,,,,,-47314000.0,,,53793000.0,-43095000.0,,,,,,,,,,,,,,,,921000.0,,19000.0,,,4322000.0,2785000.0,8000000.0,,104000.0,,,,,,,,,,,,,0.0,230000.0,0.0,0.0,,9705000.0,,,,,,,,,,,,,,,,,,,,,9513000.0,,,30367000.0,,,833000.0,,,,,,,,-276730000.0,,10698000.0,,2312000.0,22845000.0,,,,,,,,222545000.0,,,,,,,,,,2400000.0,,,,,,,,,,,,33689000.0,,,,,,,,
2015-12-31,2016-03-11,10-K,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,18804000.0,1922000.0,,,42235000.0,-70000.0,564691000.0,756000.0,54175000.0,,-75000.0,4000000.0,54050000.0,,758000.0,,4739000.0,,300116000.0,237472000.0,,,,,171713000.0,6000.0,,77000.0,171784000.0,,,59727000.0,42860000.0,112707000.0,23492000.0,113540000.0,,,0.0,200000000.0,37981000.0,37981000.0,,-182207000.0,,,,0.0,,4657000.0,,951000.0,,,,,,,0.0,600000.0,4598000.0,144000.0,,,,,27422000.0,0.0,600000.0,4541000.0,21000.0,2405000.0,,10895000.0,2285000.0,26822000.0,,600000.0,0.0,2500000.0,2989000.0,,,-6.57,,-0.0052,0.25,-0.0442,0.0,-0.1462,,-0.0415,0.0059,,-0.0388,-0.0205,10866000.0,,78027000.0,,,-75000.0,-75000.0,0.0,0.0,0.0,0.0,,,,,,1200000.0,-181268000.0,,,951000.0,13389000.0,13389000.0,,8717000.0,1633000.0,0.0,-1039000.0,,552000.0,295000.0,0.0,0.0,,-1030000.0,,1164000.0,572000.0,,,-963000.0,12764000.0,0.0,0.0,,0.0,0.0,,1900000.0,3136000.0,10005000.0,6869000.0,0.0,2096000.0,,,,,,,,,,,,300116000.0,49470000.0,,,23492000.0,81310000.0,81310000.0,111039000.0,111039000.0,-168857000.0,-168857000.0,-227047000.0,,1.0,283692000.0,-237673000.0,,,,,,,,,,,,,,,4947000.0,1078000.0,,12000.0,,200000.0,,2983000.0,8000000.0,65000.0,631000.0,5115000.0,,0.0,,0.0,,,756000.0,73011000.0,,2647000.0,2647000.0,0.0,230000.0,0.0,0.0,,,12764000.0,0.0,0.0,,,79017000.0,,79017000.0,0.0,0.0,186697000.0,,0.0,,,,0.0,3124000.0,,52108000.0,9873000.0,,,129165000.0,,800000.0,833000.0,,,,,,,,-321556000.0,,46019000.0,,9408000.0,90203000.0,,54050000.0,,,,,,243065000.0,,,3124000.0,79017000.0,0.0,,,,0.0,9198000.0,,,8031000.0,108000.0,,,,,,,,34150000.0,,,,,,,,
2016-03-31,2016-05-10,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,9092000.0,1527000.0,,,,126000.0,602117000.0,,,,,,11330000.0,,894000.0,,5633000.0,,293125000.0,238752000.0,,,,,85671000.0,,,,,,,51073000.0,34598000.0,128803000.0,,,,,0.0,200000000.0,41452000.0,41452000.0,,-41954000.0,,,,,,778000.0,,,,,,,,,,,4449000.0,1120000.0,,,,,,,,,,,,,,,,,0.0,,699000.0,,,-1.1,,,,,,,,,,,,,7824000.0,,,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,-41456000.0,,,694000.0,9494000.0,9494000.0,,-9450000.0,-395000.0,,5718000.0,,149000.0,1141000.0,0.0,,,-134000.0,,590000.0,-255000.0,,,5050000.0,-12522000.0,,0.0,,0.0,,,,2378000.0,9406000.0,5270000.0,1758000.0,10000.0,,,,,,,,,,,,293125000.0,46401000.0,,,16096000.0,,26020000.0,,16385000.0,,-26309000.0,-42150000.0,,,60052000.0,-41642000.0,,,,,,,,,,,,,,,4725000.0,823000.0,,196000.0,,,,3738000.0,8000000.0,0.0,186000.0,10165000.0,,,,,,,1782000.0,0.0,,684000.0,684000.0,0.0,230000.0,0.0,0.0,,,242000.0,,,,,27802000.0,,,,,17069000.0,,,,,,0.0,,,,10119000.0,,,35678000.0,,,833000.0,,,,,,,,-363706000.0,,18410000.0,,3311000.0,23596000.0,,11330000.0,,,,,,238537000.0,,,,,,,,,,,,,,,,,,,,,,38326000.0,,,,,,,,
2016-06-30,2016-08-09,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,7412000.0,1856000.0,,,,181000.0,732334000.0,,,,,,9904000.0,,1238000.0,,4798000.0,,374488000.0,303125000.0,,,,,212708000.0,,200000.0,,,,,101316000.0,52316000.0,148363000.0,,,,,0.0,200000000.0,47853000.0,47853000.0,,-47170000.0,,,,,,638000.0,,,,,,,,,,,4369000.0,662000.0,,,,,,,,,,,,,,,,,0.0,,,,,-1.06,,,,,,,,,,,,,9020000.0,,,,,,,0.0,0.0,0.0,0.0,,,,,,,-47189000.0,,,36000.0,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,2161000.0,9810000.0,5811000.0,1838000.0,,,,,,,,,,,,,374488000.0,44657000.0,,,,,,,,,,-47225000.0,,,52968000.0,-47497000.0,,,,,,,,,,,,,,,4913000.0,1403000.0,,55000.0,,,,3878000.0,8000000.0,,308000.0,3550000.0,,,,,,,,,,,,0.0,230000.0,0.0,0.0,,,3150000.0,,,,,,,,,,,,,,,,,,,,8811000.0,,,32069000.0,,,833000.0,,,,,,,,-410931000.0,,5471000.0,,5359000.0,20261000.0,,,,,,,,321584000.0,,,,,,,,,,,,,,,,,,,,,,44407000.0,,,,,,,,
2016-09-30,2016-11-09,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,5351000.0,873000.0,,,,39000.0,742726000.0,,,,,,9895000.0,,1422000.0,,3644000.0,,356289000.0,274035000.0,,,,,202679000.0,,,,,,,143910000.0,58769000.0,86572000.0,,,,,0.0,200000000.0,48092000.0,48092000.0,,-34104000.0,,,,,,332000.0,,,,,,,,,,,4159000.0,218000.0,,,,,,,,,,,,,,,,,0.0,,,,,-0.73,,,,,,,,,,,,,11887000.0,,,,,,,0.0,0.0,0.0,0.0,,,,,,,-33150000.0,,,812000.0,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,4351000.0,12480000.0,7292000.0,837000.0,,,,,,,,,,,,,356289000.0,45410000.0,,,,,,,,,,-33962000.0,,,52569000.0,-33494000.0,,,,,,,,,,,,,,,4095000.0,5820000.0,,-142000.0,,,,8847000.0,8000000.0,,344000.0,4319000.0,,0.0,,,,,,,,,,0.0,230000.0,0.0,0.0,,,3168000.0,,,,,,,,,,,,,,,,,,,,8832000.0,,,31951000.0,,,833000.0,,,,,,,,-444892000.0,,19075000.0,,3901000.0,20286000.0,,,,,,,,297873000.0,,,,,,,,,,,,,,,,,,,,,,46470000.0,,,,,,,,
2016-12-31,2017-03-01,10-K,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,1733000.0,646000.0,,,44244000.0,-253000.0,862708000.0,3871000.0,41290000.0,,21000.0,2500000.0,41169000.0,0.0,779000.0,179000.0,10418000.0,,639254000.0,528503000.0,,,,,571554000.0,52000.0,-300000.0,305000.0,571807000.0,,,156387000.0,91565000.0,344709000.0,232002000.0,345542000.0,232002000.0,,0.0,200000000.0,52833000.0,52833000.0,1000.0,-190852000.0,,,,222676000.0,,2894000.0,,10110000.0,,,,,,,0.0,361000.0,3966000.0,152000.0,,,,,28826000.0,0.0,361000.0,2239000.0,476000.0,3955000.0,,13208000.0,2109000.0,28465000.0,,361000.0,0.0,2200000.0,3119000.0,,,-5.62,,-0.056,0.25,-0.0089,0.0,-0.2311,,-0.0027,0.0136,,-0.0855,-0.0193,14021000.0,,74107000.0,,,21000.0,21000.0,0.0,0.0,0.0,0.0,,,,,,900000.0,-180559000.0,,,10110000.0,,-9488000.0,0.0,-16436000.0,-1276000.0,0.0,17192000.0,448000.0,632000.0,448000.0,0.0,0.0,,3182000.0,,9690000.0,-184000.0,,,-2710000.0,-9522000.0,0.0,1404000.0,1225000.0,0.0,0.0,,300000.0,3526000.0,12220000.0,6067000.0,2627000.0,603000.0,,,,,,,,,,,,639254000.0,49268000.0,,,232002000.0,479226000.0,479226000.0,-148235000.0,-148235000.0,-98989000.0,-98989000.0,-258001000.0,,1.0,292641000.0,-238301000.0,,,,,,,21678000.0,6121000.0,2758000.0,6494000.0,6305000.0,0.0,,,8298000.0,1893000.0,,-183000.0,,,,13113000.0,8000000.0,-182000.0,1312000.0,2405000.0,,0.0,,0.0,,,3871000.0,237567000.0,237567000.0,2135000.0,2135000.0,0.0,230000.0,0.0,0.0,,,3060000.0,0.0,0.0,,,253028000.0,,,222498000.0,0.0,91467000.0,,0.0,,,,4378000.0,3172000.0,,52704000.0,8460000.0,,,141712000.0,,800000.0,833000.0,,,,,,,,-512225000.0,48648000.0,54340000.0,,17603000.0,84509000.0,,41169000.0,,,,,,350231000.0,,,3172000.0,253028000.0,0.0,4378000.0,,,0.0,23254000.0,,,13899000.0,157000.0,,,,1903000.0,,,,44711000.0,,,,,,,,
2017-03-31,2017-05-10,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,3626000.0,1233000.0,,,,-272000.0,871871000.0,,,,,,10269000.0,,559000.0,,10088000.0,,588039000.0,421504000.0,,,,,420665000.0,,,,,,,222823000.0,147885000.0,169945000.0,,,,,0.0,200000000.0,53290000.0,53290000.0,1000.0,-65338000.0,,,,222942000.0,,565000.0,,,,,,,,,,,3674000.0,142000.0,,,,,,,,,,,,,,,,,0.0,,1083000.0,,,-1.27,,,,,,,,,,,,,9131000.0,,,,,,,0.0,0.0,0.0,0.0,,,,,,,-59936000.0,,,5383000.0,,0.0,,2004000.0,587000.0,,-3214000.0,,292000.0,17000.0,26000.0,,,-140000.0,,5354000.0,-266000.0,,,1237000.0,0.0,,2137000.0,,0.0,,,,3144000.0,13215000.0,7443000.0,2628000.0,0.0,,,,,,,,,,,,588039000.0,48984000.0,,,-174764000.0,-1216000.0,-1216000.0,-123522000.0,-123522000.0,-50026000.0,-50026000.0,-65319000.0,,,61916000.0,-58829000.0,,,,,,,,,,,,,,,8049000.0,1566000.0,,-19000.0,,,,18493000.0,8000000.0,-53000.0,1030000.0,3566000.0,,,,,,,4032000.0,159217000.0,159217000.0,587000.0,,0.0,230000.0,0.0,0.0,,,3083000.0,,,,,0.0,,,,,36282000.0,,,,,,2816000.0,,,,8251000.0,,,40565000.0,,833000.0,833000.0,,,,,,,,-577654000.0,3087000.0,3087000.0,,3050000.0,20786000.0,,10269000.0,,,,,,293946000.0,,,,,,,,,,,,,,,,,,,,,,51617000.0,,,,,,,,
2017-06-30,2017-08-09,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,6406000.0,1346000.0,,,,-248000.0,885315000.0,,,,,,10398000.0,,757000.0,,9376000.0,,543886000.0,384882000.0,,,,,371630000.0,,400000.0,,,,,222194000.0,136445000.0,139626000.0,,140459000.0,,,0.0,200000000.0,53829000.0,53829000.0,1000.0,-66263000.0,,,,223210000.0,,1364000.0,,,,,,,,,,,3450000.0,142000.0,,,,,,,,,,,,,,,,,0.0,,,,,-1.27,,,,,,,,,,,,,15800000.0,,,,,,,0.0,0.0,0.0,0.0,,,,,,,-65833000.0,,,454000.0,,,,,,,,,,,,,,,,,,,,,,,2137000.0,,,,,,1993000.0,12126000.0,6749000.0,3384000.0,,,,,,,,,,,,,543886000.0,57103000.0,,,,,,,,,,-66287000.0,,,68630000.0,-65121000.0,,,,,,,22967000.0,6748000.0,443000.0,3201000.0,6937000.0,2333000.0,3305000.0,,8369000.0,5047000.0,,24000.0,,,,18996000.0,8000000.0,,1425000.0,4030000.0,,,,,,,,,,,,0.0,230000.0,0.0,0.0,,,242000.0,,,,,,,,,,,,,,,,,,,,8679000.0,,,42927000.0,,,833000.0,,,,,,,,-643941000.0,3509000.0,3509000.0,,3474000.0,24339000.0,,,,,,,,241127000.0,,,,,,,,,,,,,,,,,,,,,,52255000.0,,,,,,,,
2017-09-30,2017-11-08,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,5623000.0,1576000.0,,,,-292000.0,895226000.0,,,,,,10685000.0,,724000.0,,9771000.0,,486159000.0,367133000.0,,,,,,,-300000.0,,,,,243700000.0,99399000.0,91301000.0,,92134000.0,,,0.0,200000000.0,54087000.0,54087000.0,1000.0,-66921000.0,,,,223478000.0,,985000.0,,,,,,,,,,,3288000.0,134000.0,,,,,,,,,,,,,,,,,0.0,,,,,-1.27,,,,,,,,,,,,,12714000.0,,,,,,,0.0,0.0,0.0,0.0,,,,,,,-66009000.0,,,868000.0,,,8070000.0,,,,,,,,,,,,,,,,,,,,2136000.0,,,,,,4554000.0,15258000.0,9948000.0,756000.0,,,,,,,,,,,,,486159000.0,48786000.0,,,,,,,,,,-66877000.0,,,61272000.0,-56997000.0,,,,,,,21459000.0,6763000.0,458000.0,3216000.0,6952000.0,2413000.0,1657000.0,,9828000.0,2106000.0,,-44000.0,,,,26490000.0,0.0,,1124000.0,3462000.0,8000000.0,8000000.0,,,,,,,,,,0.0,230000.0,0.0,0.0,,,289000.0,,,,,,,,,,,,,,,,,,,,8618000.0,,,39343000.0,,,833000.0,,,,,,,,-710818000.0,4275000.0,4275000.0,,4140000.0,20944000.0,,,,,,,,184117000.0,,,,,,,,,,,,,,,,,,,,,,52611000.0,,,,,,,,
2017-12-31,2018-02-28,10-K,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,5924000.0,2253000.0,,,46715000.0,-733000.0,913650000.0,8560000.0,49175000.0,,,3200000.0,49145000.0,0.0,992000.0,1072000.0,10051000.0,,441400000.0,378749000.0,,2000.0,735000.0,370961000.0,370228000.0,2000.0,0.0,735000.0,370961000.0,,370228000.0,259586000.0,41587000.0,88980000.0,-255729000.0,89813000.0,-255729000.0,,0.0,200000000.0,54381000.0,54381000.0,1000.0,-285885000.0,125000.0,1436000.0,,223746000.0,,6030000.0,,13694000.0,,,,,,,0.0,152000.0,3668000.0,125000.0,,0.0,,,42765000.0,0.0,152000.0,15834000.0,248000.0,6504000.0,,11140000.0,5293000.0,42613000.0,,152000.0,0.0,2500000.0,4027000.0,,,-7.09,,-0.0504,0.35,-0.0515,-0.0466,-0.1817,,0.0152,0.0279,,-0.0655,-0.0121,24136000.0,,83123000.0,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,8000000.0,,,-271711000.0,,170000.0,13694000.0,,4929000.0,8191000.0,3796000.0,1607000.0,,8332000.0,17000.0,298000.0,17000.0,,7890000.0,21000.0,7301000.0,,24449000.0,354000.0,,,1489000.0,-2788000.0,,8547000.0,7475000.0,,7454000.0,,3000000.0,5035000.0,16830000.0,11729000.0,66000.0,740000.0,,,,,,,,,,,,441400000.0,62552000.0,223746000.0,,,1656000.0,,-56333000.0,,-201052000.0,,-372327000.0,,1.0,359200000.0,-339299000.0,,,,,,,119644000.0,6785000.0,9522000.0,6201000.0,6974000.0,90162000.0,,,11710000.0,1883000.0,,-480000.0,3801000.0,,,34820000.0,0.0,-10000.0,4789000.0,3700000.0,8000000.0,8000000.0,,,,,8560000.0,288791000.0,288791000.0,2406000.0,,0.0,230000.0,0.0,0.0,,,291000.0,,,,,0.0,,,0.0,,234864000.0,,0.0,0.0,,,6236000.0,3980000.0,2250000.0,56872000.0,10157000.0,,,173887000.0,833000.0,,833000.0,,,,,,,,-797740000.0,19901000.0,19901000.0,,14788000.0,95592000.0,,49145000.0,,,,,,115178000.0,,,3980000.0,1000.0,0.0,6236000.0,,,0.0,41794000.0,51000.0,,18591000.0,51000.0,,,509000.0,2290000.0,6346000.0,-6468000.0,52352000.0,52352000.0,,53703000.0,,,,,,
2018-03-31,2018-05-09,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,5085000.0,1973000.0,,,,-854000.0,925968000.0,1715000.0,13998000.0,,,,13998000.0,0.0,888000.0,,10597000.0,,480108000.0,446818000.0,,1000.0,855000.0,404672000.0,,,,,,,403818000.0,292700000.0,16999000.0,125831000.0,,126664000.0,36851000.0,,0.0,200000000.0,54798000.0,54798000.0,1000.0,-65207000.0,,,16000.0,224014000.0,,,1119000.0,,,,,,,,,,5772000.0,,,,,,,,,,,,,,,,,,0.0,,1007000.0,,,-1.22,,,0.21,,,,,,,,,,21989000.0,,,,,,,0.0,0.0,0.0,0.0,,,,,,,-64943000.0,,686000.0,144000.0,,4473000.0,3324000.0,-449000.0,-280000.0,,-5076000.0,95371000.0,-2104000.0,,,-5092000.0,,371000.0,,1267000.0,,,,1578000.0,,,2137000.0,,,,,,4620000.0,17217000.0,10611000.0,1986000.0,,,,,,,,,,,,,480108000.0,105179000.0,,,,-1680000.0,,-11294000.0,,49825000.0,,-65087000.0,1100000.0,,73295000.0,-64976000.0,,,,,,,,,,,,,,,11508000.0,1805000.0,,-120000.0,,,,36085000.0,,397000.0,1484000.0,5326000.0,,,,,,,1715000.0,,54839000.0,2771000.0,,0.0,230000.0,0.0,0.0,,,926000.0,,,,4473000.0,,,,,,46299000.0,,,0.0,17000.0,,35000.0,,,,10329000.0,,,47765000.0,,833000.0,833000.0,,,,,,,,-861708000.0,8319000.0,8319000.0,,,24704000.0,,13998000.0,,,,,,63407000.0,,,,,,35000.0,,,,,,,,,,,-447000.0,1777000.0,1735000.0,-1802000.0,,53256000.0,,,,,,,,
2018-06-30,2018-08-02,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,3644000.0,3434000.0,,,,-525000.0,937437000.0,5190000.0,13871000.0,,,,13855000.0,,1299000.0,,10463000.0,,421364000.0,386693000.0,,4000.0,530000.0,355577000.0,,,,,,,355051000.0,249049000.0,18252000.0,103854000.0,,104687000.0,,,0.0,200000000.0,55104000.0,55104000.0,1000.0,-40489000.0,54478000.0,34220000.0,16000.0,224282000.0,,,,,,0.0,,,,,,,6670000.0,,,,,,,,,,,,,,,,,,,,,,,-0.76,,,,,,,,,,,,,12150000.0,,,,,,,0.0,0.0,0.0,0.0,,,,,,,-47608000.0,,1949000.0,-6790000.0,,,3143000.0,,,,,,,,,,,,,,,,,,,,2137000.0,,,,,,3978000.0,17906000.0,10579000.0,3349000.0,,,,,,,,,,,,,421364000.0,93480000.0,,,,,,,,,,-40818000.0,1100000.0,,72180000.0,-48704000.0,,,,,,,,,,,,,,,8700000.0,1766000.0,,329000.0,,,,28325000.0,,,1284000.0,7641000.0,,,,,,,,,,,,0.0,230000.0,0.0,0.0,,,944000.0,,,,,,,,,,,,,0.0,,,,,,,10677000.0,,,48621000.0,,,833000.0,,,,,,,,-902526000.0,23476000.0,,,,25007000.0,,,978750.0,,,,,34387000.0,,,2742000.0,,,46000.0,,,,,,,,,,,,2343000.0,,,53799000.0,53799000.0,,54958000.0,,,,,,
2018-09-30,2018-11-08,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,3745000.0,3024000.0,,,,-331000.0,948844000.0,1548000.0,11730000.0,,,,11746000.0,0.0,1062000.0,,10463000.0,,370964000.0,332606000.0,,3000.0,336000.0,308574000.0,,,,,,,308241000.0,199207000.0,20217000.0,101202000.0,,102035000.0,,,0.0,200000000.0,55410000.0,55410000.0,1000.0,-59239000.0,57239000.0,22469000.0,7000.0,224550000.0,,,,,,0.0,,,,,,,7038000.0,,,,,,,,,,,,,,,,,,,,,,,-1.1,,,,,,,,,,,,,15893000.0,,,0.85,,,,0.0,0.0,0.0,0.0,,,,,,,-60092000.0,,3119000.0,-659000.0,,,3131000.0,,,,,,,,,,,,,,,,,,,,2137000.0,,,,,,3510000.0,17923000.0,10785000.0,3628000.0,,,,,,,,,,,,,370964000.0,102029000.0,,,,,,,,,,-59433000.0,1100000.0,,75288000.0,-62450000.0,,,,,,,,,,,,,,,11052000.0,1762000.0,,194000.0,,,,28323000.0,,,1376000.0,7029000.0,,,,,,,,,,,,0.0,230000.0,0.0,0.0,,,314000.0,,,,,,,,,,,,,0.0,,,,,,,12415000.0,,,52693000.0,833000.0,,833000.0,,,,,,,,-961959000.0,12838000.0,,,,21890000.0,,,978750.0,,,,,-13445000.0,,,,,,1225000.0,,,,,,,,,,,,2286000.0,,,54248000.0,54248000.0,,55230000.0,,,,,,
2018-12-31,2019-02-28,10-K,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,9028000.0,620000.0,,,49695000.0,-166000.0,960721000.0,9808000.0,51313000.0,,,1900000.0,51313000.0,0.0,0.0,1166000.0,10170000.0,,560235000.0,532823000.0,,8000.0,174000.0,501837000.0,,,,,,,501671000.0,127255000.0,11869000.0,378021000.0,,378854000.0,289041000.0,,0.0,200000000.0,55681000.0,55681000.0,1000.0,-214957000.0,43402000.0,26179000.0,130000.0,224818000.0,,,1119000.0,-10561000.0,,0.0,,,,,,208000.0,7976000.0,,,19409000.0,,282700000.0,367956000.0,0.0,208000.0,33396000.0,0.0,8508000.0,,12479000.0,8343000.0,367748000.0,,208000.0,0.0,3000000.0,3166000.0,5422000.0,,-4.91,,0.0467,0.21,,,,,,,,,,23803000.0,,86855000.0,0.85,,,,0.0,0.0,0.0,0.0,,6056000.0,,,0.0,,-226085000.0,,11182000.0,-10561000.0,,-7316000.0,,3575000.0,-1633000.0,,-12357000.0,69224000.0,-4308000.0,,,-8191000.0,1841000.0,1629000.0,,-10058000.0,-45000.0,,,225000.0,,,10482000.0,9316000.0,,7475000.0,3086000.0,,,0.0,,,,,,,,,,,,,,,560235000.0,98554000.0,454353000.0,,,225200000.0,,176708000.0,,-112867000.0,,-265710000.0,,1.0,377479000.0,-301372000.0,7985000.0,,,,,,113912000.0,7817000.0,9766000.0,9501000.0,6547000.0,80281000.0,,,7359000.0,1534000.0,,567000.0,4481000.0,,,24762000.0,,43000.0,11966000.0,11452000.0,,8000000.0,,,,,9807000.0,,183261000.0,7240000.0,,0.0,230000.0,0.0,0.0,0.0,,310000.0,,,20000000.0,,,,,,,347192000.0,,,0.0,17000.0,17000.0,1393000.0,4173000.0,,62871000.0,13176000.0,,,201348000.0,833000.0,,800000.0,,833000.0,,,,,,-1012145000.0,76107000.0,,,,97058000.0,,51313000.0,,,,,,-51589000.0,,,4173000.0,,,1393000.0,,,0.0,52404000.0,685000.0,,11295000.0,685000.0,,,-362000.0,1528000.0,7627000.0,-8027000.0,53969000.0,53969000.0,,55076000.0,,,,,,
2019-03-31,2019-05-10,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,5596000.0,113000.0,,,,-36000.0,971508000.0,1687000.0,12220000.0,,,,12220000.0,,0.0,,12158000.0,,531265000.0,467233000.0,,59000.0,95000.0,425355000.0,,,,,,,425319000.0,210823000.0,,223235000.0,,224068000.0,-154786000.0,,0.0,200000000.0,56122000.0,56122000.0,1000.0,-72450000.0,42515000.0,21733000.0,5333000.0,225086000.0,,,,-100000.0,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,1316000.0,,,-1.32,,,,,,,,,,,,,22097000.0,,,0.85,,,,0.0,0.0,0.0,0.0,986000.0,,,,,,-72500000.0,,6229000.0,80000.0,,,,-3440000.0,-507000.0,,-2703000.0,-5333000.0,,,,,-4581000.0,,,73000.0,,,,2135000.0,,,7858000.0,,,,10240000.0,,,,,,,,,113357000.0,70208000.0,,10035000.0,9757000.0,9492000.0,7253000.0,6612000.0,40126000.0,531265000.0,113542000.0,,,,-1433000.0,,-72160000.0,,-81193000.0,,-72580000.0,,,79004000.0,-73666000.0,2781000.0,56913000.0,8420000.0,48493000.0,2200000.0,48861000.0,,,,,,,,0.0865,15587000.0,1439000.0,,130000.0,1316000.0,,,14261000.0,,-16000.0,2795000.0,24928000.0,,,3400000.0,,,,1687000.0,,148138000.0,1220000.0,,0.0,230000.0,0.0,0.0,,,310000.0,,,,,,,,,,77198000.0,,,0.0,,,254000.0,,,,12899000.0,,,53818000.0,833000.0,,833000.0,,,,,,,,-1084725000.0,5338000.0,,49847000.0,,25186000.0,3900000.0,12220000.0,,,,,,-113252000.0,,,,,,254000.0,,16318000.0,,,,,,,,,,,,,54938000.0,54938000.0,,55818000.0,,,,,,
2019-06-30,2019-08-05,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,3501000.0,111000.0,,,,129000.0,987209000.0,494000.0,11298000.0,,,,11298000.0,,0.0,,14144000.0,,492447000.0,426038000.0,,162000.0,33000.0,367178000.0,,,,,,,367307000.0,217761000.0,,178311000.0,,179144000.0,,,0.0,200000000.0,56637000.0,56637000.0,1000.0,-39673000.0,43311000.0,13444000.0,7492000.0,225354000.0,,,,-200000.0,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,20019000.0,,-0.72,,,,,,,,,,,,,23495000.0,,,0.85,,,,0.0,0.0,0.0,0.0,,,,,,,-39637000.0,,8366000.0,201000.0,,,3695000.0,,,,,,,,,,,,,,,,,,,,7901000.0,,,,5758000.0,,,,,,,,,111153000.0,70208000.0,,10035000.0,9757000.0,9492000.0,7253000.0,4408000.0,38927000.0,492447000.0,110136000.0,,,,,,,,,,-39838000.0,,,68626000.0,-42476000.0,2614000.0,56452000.0,7887000.0,48565000.0,1700000.0,47831000.0,,,,,,,,0.0865,6432000.0,1388000.0,,165000.0,,,,14457000.0,,,2374000.0,8857000.0,,,,,,,,,,,,0.0,230000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,0.0,,,,,,,12662000.0,,,46399000.0,833000.0,,833000.0,,,,,,,,-1124563000.0,26150000.0,,,,22227000.0,,,,,,,,-137224000.0,,,2605000.0,,,2292000.0,,15774000.0,,,,,,,,,,,,,55529000.0,55529000.0,,56407000.0,,,,,,
2019-09-30,2019-11-08,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,8713000.0,87000.0,,,,94000.0,1000094000.0,562000.0,13019000.0,,,,13019000.0,,0.0,,14016000.0,,445337000.0,355652000.0,,119000.0,23000.0,334673000.0,,,,,,,334769000.0,217278000.0,24939000.0,102403000.0,,110732000.0,,,0.0,200000000.0,56762000.0,56762000.0,1000.0,-58466000.0,33751000.0,14169000.0,8836000.0,225622000.0,,,,-5600000.0,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,16661000.0,,-1.05,,,,,,,,,,,,,25801000.0,,,,,,,,0.0,0.0,,,,,,,,-63983000.0,,7197000.0,-5552000.0,,,3664000.0,,,,,,,,,,,,,,,,,,,,8068000.0,,,,7568000.0,,,,,,,,,108866000.0,70172000.0,,10024000.0,9746000.0,9481000.0,7242000.0,2201000.0,37692000.0,445337000.0,108823000.0,,,,,,,,,,-58431000.0,,,77628000.0,-65201000.0,2750000.0,55453000.0,6833000.0,48620000.0,2100000.0,46755000.0,,,,,,,,0.0865,6549000.0,1305000.0,,-35000.0,,,,8900000.0,,,2089000.0,7132000.0,,,,,,,,,,,,0.0,230000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,0.0,,,,,,,12189000.0,,,52006000.0,8329000.0,,,7496000.0,833000.0,,,,,,-1182994000.0,12427000.0,,,,25622000.0,,,,,,,,-182805000.0,,,,,,428000.0,,15721000.0,,,,,,,,,,,,,55858000.0,55858000.0,,56690000.0,,,,,,
2019-12-31,2020-02-27,10-K,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,4758000.0,,,,47568000.0,145000.0,1024614000.0,3173000.0,60450000.0,,,2400000.0,60450000.0,,0.0,3051000.0,13253000.0,,408826000.0,338488000.0,,148000.0,3000.0,274014000.0,,,,,,,274159000.0,222767000.0,4985000.0,58064000.0,,58897000.0,-319957000.0,,0.0,200000000.0,57015000.0,57015000.0,1000.0,-236144000.0,31575000.0,6761000.0,31245000.0,225890000.0,,,,-5222000.0,,0.0,33644000.0,3000.0,33644000.0,3000.0,,9888000.0,,,,19409000.0,,282700000.0,413724000.0,,9888000.0,58161000.0,7000.0,15723000.0,,15480000.0,8245000.0,403836000.0,,459000.0,0.0,3300000.0,,28574000.0,-4.25,-5.42,-4.25,0.0216,0.21,,,,,,,,,,28180000.0,,112908000.0,,,,,0.0,0.0,0.0,0.0,3224000.0,,,,0.0,,-241677000.0,,33705000.0,-5222000.0,,22000.0,3682000.0,-4274000.0,-620000.0,,10626000.0,-31245000.0,,,,3700000.0,2573000.0,,-2317000.0,-4748000.0,358000.0,,,73000.0,,,31862000.0,28811000.0,,26178000.0,5659000.0,,,,,,,,,107357000.0,59860000.0,7940000.0,10309000.0,10023000.0,9745000.0,9480000.0,,36309000.0,408826000.0,111703000.0,455041000.0,,,1291000.0,,-83051000.0,,-238197000.0,,-302061000.0,,1.0,425400000.0,-322487000.0,8123000.0,55487000.0,7762000.0,47725000.0,7210000.0,46604000.0,,,,,,,,0.0865,1937000.0,1590000.0,,311000.0,6441000.0,,,21287000.0,,-146000.0,8395000.0,4351000.0,,,,,,,3173000.0,,423898000.0,3176000.0,,0.0,230000.0,0.0,0.0,0.0,,,,,5000000.0,,,,,,,339018000.0,,,0.0,5000.0,5000.0,3142000.0,3474000.0,,60212000.0,12644000.0,,2152000.0,219248000.0,833000.0,,800000.0,,833000.0,,,,,,-1248600000.0,102913000.0,,49847000.0,,106081000.0,3500000.0,60450000.0,,,,,,-223840000.0,,,3474000.0,,,3142000.0,,,0.0,58763000.0,2010000.0,,8369000.0,,-8000000.0,,199000.0,1261000.0,,-466000.0,55610000.0,55610000.0,,55610000.0,,200000.0,,,,
2020-03-31,2020-05-08,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,6645000.0,,,,,512000.0,1173204000.0,6804000.0,15276000.0,,,,15276000.0,,,,12711000.0,,605409000.0,534218000.0,,555000.0,41000.0,432589000.0,,,,,,,433103000.0,154233000.0,5067000.0,332798000.0,,333631000.0,274734000.0,,0.0,200000000.0,63004000.0,63004000.0,1000.0,-82686000.0,23193000.0,8511000.0,,226158000.0,,,,,0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26282000.0,-1.4,-1.4,-1.4,,,,,,,,,,,,24708000.0,,,,,,,,,,,457000.0,,-15464000.0,,,,-82906000.0,,13515000.0,147000.0,,-9000.0,3972000.0,1154000.0,,,-10549000.0,-6632000.0,,,,,664000.0,,,144000.0,99000.0,,,-1592000.0,,,9941000.0,,,7891000.0,6323000.0,,,,,,,,,,,,,,,,,,605409000.0,98040000.0,,,,261432000.0,,68403000.0,,-55101000.0,,-83053000.0,,,92338000.0,-72476000.0,,,7954000.0,47199000.0,,46106000.0,,,,,,,,,6559000.0,1308000.0,,367000.0,2424000.0,,,9583000.0,,-9000.0,1460000.0,5491000.0,,,,,5065000.0,11470000.0,6804000.0,,64778000.0,954000.0,,0.0,230000.0,0.0,0.0,0.0,,,,,14932000.0,,139915000.0,380000000.0,,,,119203000.0,14932000.0,,14900000.0,,,203000.0,,,,13905000.0,,235347000.0,66013000.0,833000.0,,,,833000.0,,,,,,-1331653000.0,19862000.0,,,,26325000.0,,15276000.0,,,,,,-157936000.0,,,,139915000.0,,203000.0,,,,,,,,,,,,,,,59463000.0,59463000.0,,60076000.0,,,,,,
2020-06-30,2020-08-10,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,10065000.0,,,,,280000.0,1191923000.0,1144000.0,16585000.0,,,,16585000.0,,,,12389000.0,,564330000.0,498386000.0,,284000.0,4000.0,383957000.0,,,,,,,384237000.0,333605000.0,,104735000.0,,105568000.0,,,0.0,200000000.0,63515000.0,63515000.0,1000.0,-63119000.0,25062000.0,1154000.0,,226427000.0,,,,,,,59965000.0,3000.0,59965000.0,3000.0,,,,,,,,,,,,,,,,,,,,,0.0,,,35509000.0,-1.0,-1.0,-1.0,,,,,,,,,,,,26757000.0,,,,,,,,,,,,,,,,,-62848000.0,,21381000.0,39000.0,,,3986000.0,,,,,,,,,,,,,,,,,,,,11391000.0,,,,3702000.0,,,,,,,,,,,,,,,,,,564330000.0,106574000.0,,,,,,,,,,-62887000.0,,,87184000.0,-72176000.0,,,8741000.0,47631000.0,,45184000.0,,,,,,,,,7018000.0,1508000.0,,-232000.0,,,,9614000.0,,,-662000.0,13124000.0,,,,,,,,,,,,0.0,230000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,5000000.0,,,,,,,14433000.0,,,62404000.0,833000.0,,,,833000.0,,,,,,-1394540000.0,15008000.0,,,,24780000.0,,,,,,,,-202336000.0,,,2545000.0,,,733000.0,,,,,,,,,,,,,,,62861000.0,62861000.0,,63275000.0,,,,,,
2020-09-30,2020-11-09,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,6442000.0,,,,,122000.0,1206524000.0,987000.0,15564000.0,,,,15564000.0,,,,14739000.0,,512188000.0,450724000.0,,126000.0,1000.0,307553000.0,,,,,,,307678000.0,265065000.0,,93282000.0,,94115000.0,,,0.0,200000000.0,63956000.0,63956000.0,1000.0,-73801000.0,18204000.0,750000.0,,226695000.0,,,,,,,15088000.0,1000.0,15088000.0,1000.0,,,,,,,,,,,,,,,,,,,,,0.0,,,48909000.0,-1.16,-1.16,-1.16,,,,,,,,,,,,30472000.0,,,,,,,,,,,,,,,,,-73550000.0,,13403000.0,93000.0,,,,,,,,,,,,,,,,,,,,,,,11573000.0,,,,5791000.0,,,,,,,,,,,,,,,,,,512188000.0,104270000.0,,,,,,,,,,-73643000.0,,,94872000.0,-76615000.0,,,9685000.0,47823000.0,,44391000.0,,,,,,,,,6732000.0,810000.0,,-158000.0,,,,9704000.0,,,1235000.0,10308000.0,,,,,,,,,,,,0.0,230000.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,15430000.0,,,67371000.0,833000.0,,,,833000.0,,,,,,-1468183000.0,18257000.0,,,,27501000.0,,,,,,,,-261536000.0,,,,,,24000.0,,,,,,,,,,,,,,,63303000.0,63303000.0,,63303000.0,,,,,,
2020-12-31,2021-02-26,10-K,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,6775000.0,,,,45808000.0,47000.0,1222818000.0,9749000.0,62976000.0,,,6300000.0,62976000.0,,,1960000.0,13229000.0,,469057000.0,393341000.0,,53000.0,6000.0,211427000.0,,,,,,,211474000.0,211474000.0,,81467000.0,,82300000.0,23403000.0,,1e-05,200000000.0,64328000.0,64328000.0,1000.0,-278115000.0,11523000.0,348000.0,,226963000.0,,,,-8520000.0,,0.0,44420000.0,6000.0,44420000.0,6000.0,,9021000.0,,,,19409000.0,,,471732000.0,,9021000.0,82821000.0,346000.0,24075000.0,,15087000.0,8145000.0,462711000.0,,341000.0,0.0,3300000.0,,53799000.0,-5.38,-5.38,-5.38,0.0297,,,,,,,,,,,35238000.0,,114725000.0,,12750000.0,,,0.0,0.0,0.0,0.0,3344000.0,,-15464000.0,,0.0,,-286537000.0,,68438000.0,-8520000.0,,14000.0,,3658000.0,,,5983000.0,-26465000.0,,,,258000.0,-1685000.0,,1600000.0,-7606000.0,852000.0,,,2327000.0,,,44585000.0,42625000.0,,24024000.0,3974000.0,,,,,,,,,101118000.0,49309000.0,10330000.0,10649000.0,10351000.0,10134000.0,10345000.0,,31978000.0,469057000.0,123571000.0,619170000.0,,,263085000.0,,10721000.0,,-250403000.0,,-336451000.0,,1.0,464834000.0,-374247000.0,8732000.0,57087000.0,9867000.0,47220000.0,3804000.0,43260000.0,,,,,,,,0.0864,2013000.0,2451000.0,,-98000.0,6798000.0,,,1833000.0,,95000.0,2831000.0,10359000.0,,,,,5326000.0,11470000.0,9749000.0,,401987000.0,6616000.0,,1e-05,230000.0,0.0,0.0,,,,,,,,139915000.0,380000000.0,,,,399318000.0,19942000.0,,19900000.0,,64000.0,1361000.0,3701000.0,,62230000.0,16422000.0,,235347000.0,260953000.0,833000.0,,,,833000.0,,,,,,-1526617000.0,90587000.0,,,,108661000.0,,62976000.0,,0.53,,,,-303751000.0,,,3701000.0,139915000.0,,1361000.0,,,0.0,63447000.0,8059000.0,,12743000.0,,,,,,,,62345000.0,62345000.0,,62345000.0,,-300000.0,,,,
2021-03-31,2021-05-06,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,6834000.0,,,,,17000.0,1233060000.0,5593000.0,15832000.0,,,,15832000.0,,,,15159000.0,,375108000.0,293071000.0,,20000.0,1000.0,157252000.0,,,,,,,157271000.0,95957000.0,,114011000.0,,114844000.0,32544000.0,,1e-05,200000000.0,65218000.0,65218000.0,1000.0,-79709000.0,7661000.0,339000.0,,227230000.0,,,,,,0.0,5012000.0,1000.0,5012000.0,1000.0,,,,,,,,,,,,,,,,,,,,,0.0,,,42359000.0,-1.24,-1.24,-1.24,,,,,,,,,,,,15624000.0,,,,19439000.0,,,0.0,,,,743000.0,,,,,,-79452000.0,,16547000.0,200000.0,,,,-1073000.0,,,-17299000.0,-3871000.0,,,,,1830000.0,,,224000.0,-65000.0,,,-322000.0,,,11873000.0,,,14385000.0,5804000.0,,,,,,,,,,,,,,,,,,375108000.0,86492000.0,614070000.0,,,-11288000.0,,113697000.0,,-69865000.0,,-79679000.0,,,98149000.0,-83892000.0,,,1220000.0,57026000.0,,42517000.0,,,,,,,,,1833000.0,2304000.0,,-30000.0,1539000.0,,,2058000.0,,-46000.0,-234000.0,10037000.0,,,,,,,5593000.0,,36000.0,1767000.0,,1e-05,230000.0,0.0,0.0,,,,,,,,,,,,,115500000.0,,,,,,3000.0,,,,16944000.0,,5698000.0,67599000.0,833000.0,,,,833000.0,,,,,,-1606296000.0,14257000.0,,,,30550000.0,,15832000.0,,,,,,-373218000.0,,,,,,3000.0,,,,,,,,,,,,,,,64493000.0,64493000.0,,64723000.0,,,,,,
2021-06-30,2021-08-05,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,10702000.0,,,,,8000.0,1358318000.0,727000.0,14941000.0,,,,14941000.0,,,,12904000.0,,429251000.0,333180000.0,,8000.0,,235489000.0,,,,,,,235497000.0,60004000.0,,204949000.0,,205782000.0,,,1e-05,200000000.0,73470000.0,73470000.0,1000.0,-52414000.0,5690000.0,329000.0,,227499000.0,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,27741000.0,-0.8,-0.8,-0.8,,,,,,,,,,,,14635000.0,,,,35822000.0,,,0.0,,,,,,,,,,-52625000.0,,21926000.0,-220000.0,,,,,,,,,,,,,,,,,,,,,,,11612000.0,,,,3900000.0,,,,,,,,,,,,,,,,,,429251000.0,67127000.0,609509000.0,,,,,,,,,-52405000.0,,,77024000.0,-64110000.0,,,1037000.0,57768000.0,,41508000.0,,,,,,,,,1496000.0,1325000.0,,-9000.0,,,,1833000.0,,,1171000.0,12353000.0,,,,,,,,,,,,1e-05,230000.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,16583000.0,,,51093000.0,833000.0,,,,833000.0,,,,,,-1658701000.0,12914000.0,,,,25931000.0,,,,,,,,-300374000.0,,,2862000.0,108180000.0,,2000.0,,,,,,,,,,,,,,,65669000.0,65669000.0,,65669000.0,,,,,,
2021-09-30,2021-11-08,10-Q,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,8900000.0,,,,,14000.0,1370402000.0,2286000.0,14370000.0,,,,14370000.0,,,,15576000.0,8000.0,403109000.0,297172000.0,,10000.0,,185614000.0,,,,,,,185624000.0,94789000.0,,121424000.0,,122257000.0,,,1e-05,200000000.0,73698000.0,73698000.0,1000.0,-35302000.0,2902000.0,320000.0,,227767000.0,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,43773000.0,-0.48,,-0.48,,,,,,,,,,,,8635000.0,,,,45086000.0,,,0.0,0.0,,,,,,,,,-35315000.0,,30208000.0,-7000.0,,,,,,,,,,,,,,,,,,,,,,,11742000.0,,,,5808000.0,,,,,,,,,,,,,,,,,,403109000.0,66082000.0,615867000.0,,,,,,,,,-35308000.0,,,66809000.0,-53615000.0,,,1016000.0,54353000.0,,40718000.0,,,,,,,,,1830000.0,3297000.0,,6000.0,,,,2609000.0,,,-166000.0,9943000.0,,,,,,,,,,,,1e-05,230000.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,16003000.0,,,43739000.0,833000.0,,,,833000.0,,,1771000.0,1771000.0,,-1694009000.0,13194000.0,,,,21299000.0,1771000.0,,,,,,,-323592000.0,,,,,,,,,,,,,,,,,,,,,73574000.0,,,73574000.0,,,,,,
2021-12-31,2022-02-28,10-K,"THERAVANCE BIOPHARMA,Â INC.",TBPH,CIK0001583107,USD,3098000.0,,,,38492000.0,,1387469000.0,9061000.0,62061000.0,,,9300000.0,62061000.0,,,2182000.0,14145000.0,,374819000.0,249870000.0,,1000.0,5000.0,133738000.0,,,,,,,133734000.0,83506000.0,,89959000.0,,90796000.0,8496000.0,,1e-05,200000000.0,74435000.0,74435000.0,1000.0,-199473000.0,98000.0,310000.0,,228035000.0,,,,-151000.0,,0.0,35017000.0,5000.0,35017000.0,5000.0,,8830000.0,,,,19409000.0,,,486698000.0,,8830000.0,115606000.0,10505000.0,28372000.0,,10432000.0,3590000.0,477868000.0,,254000.0,0.0,3500000.0,,43534000.0,-3.3000000000000003,,-3.3000000000000003,0.0008,,,,,,,,,,,12796000.0,,93551000.0,,67537000.0,,,0.0,0.0,,,3786000.0,,,,0.0,,-199577000.0,,103987000.0,-151000.0,,-4089000.0,,-3534000.0,,,-37225000.0,-11463000.0,,,,,-34000.0,,-1742000.0,587000.0,972000.0,,,-2867000.0,,,46889000.0,44707000.0,,39029000.0,3940000.0,,,,,,,,,86020000.0,36552000.0,9390000.0,10425000.0,10133000.0,9865000.0,9655000.0,,22622000.0,374819000.0,58587000.0,616334000.0,,,91860000.0,,124494000.0,,-207858000.0,,-231460000.0,,1.0,384208000.0,-313951000.0,7625000.0,53184000.0,503000.0,52681000.0,8971000.0,39690000.0,,,,,,,,0.0864,1304000.0,3228000.0,,-47000.0,5912000.0,,,2420000.0,,-10000.0,1109000.0,8561000.0,,,,,,,9061000.0,,158305000.0,3406000.0,,1e-05,230000.0,0.0,0.0,,,,,,,,108180000.0,,,,,286199000.0,,,,,6000.0,5000.0,3466000.0,,52149000.0,13657000.0,,10730000.0,193657000.0,837000.0,,,,837000.0,,,20142000.0,9550000.0,11867000.0,-1726043000.0,70257000.0,,,,99296000.0,,62061000.0,,,2800000.0,,,-338573000.0,,,3466000.0,108180000.0,,5000.0,,,,75023000.0,395000.0,,11971000.0,,,,,,,,69461000.0,,,69461000.0,,-900000.0,-39000.0,2317000.0,17000000.0,
